There are no investor materials for this year.
Pharmakon Advisors LP (the “Manager”) is required to produce and publish this document by Regulation (EU) 1286/2014 of the European Parliament and the Council on key information documents for packaged retail and insurance-based investment products (the “Regulation”). The Manager is required to follow the Regulation’s prescribed methodology in preparing the document, including for the determination of the summary risk indicator and calculation of the performance scenarios. In accordance with this prescribed methodology, the performance scenarios represent extrapolations of a recent positive share price trend and, as such, may deviate substantially from expectations of performance which do not similarly rely on such extrapolations or assume past performance will be a guide to future performance.
Pharmakon Advisors LP (the “Manager”) is using the European MiFID Template (EMT) as the format to disseminate information to distributors about BioPharma Credit plc (the “Company”). The EMT is strictly for information purposes and should not be considered as an offer, investment recommendation or solicitation to deal in the shares of the Company and do not constitute investment research. The Manager has prepared the EMT using information it reasonably considers to be accurate. However, the Manager makes no warranty that the information contained in the EMT is appropriate or sufficient for any particular use or in any particular territory.